Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity-Reference-Cited by-同舟云学术

Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity

Published:2023-08 Issue:8 Volume:42 Page:112827
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Chen Yuan,Mason Georgina H.,Scourfield D. Oliver,Greenshields-Watson Alexander,Haigh Tracey A.,Sewell Andrew K.,Long Heather M.,Gallimore Awen M.,Rizkallah Pierre,MacLachlan Bruce J.^ORCID,Godkin Andrew^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference100 articles.

1. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity;Rydyznski Moderbacher;Cell,2020

2. Convergent antibody responses to SARS-CoV-2 in convalescent individuals;Robbiani;Nature,2020

3. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults;Anderson;N. Engl. J. Med.,2020

4. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial;Folegatti;Lancet,2020

5. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans;Sahin;Nature,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the landscape of the SARS‐CoV‐2‐specific T cells post‐omicron surge;Journal of Medical Virology;2024-08

2. Lower Humoral and Cellular Immunity Following Asymptomatic SARS-CoV-2 Infection Compared to Symptomatic Infection in Education (The ACE Cohort);Journal of Clinical Immunology;2024-06-10

3. Lower Humoral and Cellular Immunity following Asymptomatic SARS-CoV-2 Infection in Education (The ACE Cohort);2024-01-31

4. Pre-existing SARS-2-specific T cells are predicted to cross-recognize BA.2.86;Cell Host & Microbe;2024-01

5. De novo design of anti-variant COVID-19 vaccine;Biology Methods and Protocols;2023-01-01